Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPΒ

Oncogene

Volumn 28, Issue 12, 2009, Pages 1561-1568

  Gustafson, T L ^a   Wellberg, E ^a   Laffin, B ^a   Schilling, L ^a   Metz, R P ^a   Zahnow, C A ^b   Porter, W W ^a,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

C EBP beta; Mammary gland; NOTCH; Singleminded 2s

Indexed keywords

C REPEAT BINDING FACTOR 1 PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; MESSENGER RNA; NOTCH RECEPTOR; NUCLEIC ACID BINDING PROTEIN; SINGLEMINDED 2S PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL IMMORTALIZATION; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENES, RAS; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MICE; NEOPLASM INVASIVENESS; RECEPTORS, NOTCH; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 63449108743     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.497     Document Type: Article

References (38)

1. Aleman MJ, DeYoung MP, Tress M, Keating P, Perry GW, Narayanan R. (2005). Inhibition of Single Minded 2 gene expression mediates tumor-selective apoptosis and differentiation in human colon cancer cells. Proc Natl Acad Sci USA 102: 12765-12770.
2. Baldwin BR, Timchenko NA, Zahnow CA. (2004). Epidermal growth factor receptor stimulation activates the RNA binding protein CUG-BP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. Mol Cell Biol 24: 3682-3691.
3. Bray SJ. (2006). Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7: 678-689.
4. Crews S, Franks R, Hu S, Matthews B, Nambu J. (1992). Drosophila single-minded gene and the molecular genetics of CNS midline development. J Exp Zool 261: 234-244.
5. Descombes P, Schibler U. (1991). A liver enriched transcriptional activator protein, LAP, and a transcriptional inhibitors protein, LIP, are transcribed from the same mRNA. Cell 3: 569-579.
6. Deyoung MP, Scheurle D, Damania H, Zylberberg C, Narayanan R. (2002). Down's syndrome-associated single minded gene as a novel tumor marker. Anticancer Res 22: 3149-3157.
7. Dunn KL, Espino PS, Drobic B, He S, Davie JR. (2005). The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol 83: 1-14.
8. Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J. (2006). C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10: 203-214.
9. Grimm SL, Rosen JM. (2003). The role of C/EBPbeta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 8: 191-204.
10. Halvorsen OJ, Rostad K, Oyan AM, Puntervoll H, Bo TH, Stordrange L et al. (2007). Increased expression of SIM2-s protein is a novel marker of aggressive prostate cancer. Clin Cancer Res 13: 892-897.
11. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. (1995). Signalling downstream of activated mammalian Notch. Nature 377: 355-358.
12. Kewley RJ, Whitelaw ML, Chapman-Smith A. (2004). The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol 36: 189-204.
13. Khleif SN, Abrams SI, Hamilton JM, Bergmann-Leitner E, Chen A, Bastian A et al. (1999). A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumors. J Immunother 22: 155-165.
14. Kiaris H, Politi K, Grimm LM, Szabolcs M, Fisher P, Efstratiadis A et al. (2004). Modulation of Notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. Am J Pathol 165: 695-705.
15. Kwak HI, Gustafson T, Metz RP, Laffin B, Schedin P, Porter WW. (2007). Inhibition of breast cancer growth and invasion by singleminded 2s. Carcinogenesis 2: 259266.
16. Laffin B, Wellberg E, Kwak HI, Burghardt RC, Metz RP, Gustafson T et al. (2008). Loss of Singleminded-2s in the mouse mammary gland induces an epithelial mesenchymal transition associated with up-regulation of Slug and MMP2. Mol Cell Biol 28: 1936-1946.
17. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS et al. (2003). A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114: 323-334.
18. Liu S, Dontu G, Wicha MS. (2005). Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 7: 8695.
19. Martinez Arias A, Zecchini V, Brennan K. (2002). CSL-independent Notch signalling: a checkpoint in cell fate decisions during development? Curr Opin Genet Dev 12: 524533.
20. Martinez-Lacaci I, Kannan S, De Santis M, Bianco C, Kim N, Wallace-Jones B et al. (2000). RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. Int J Cancer 88: 44-52.
21. Metz RP, Kwak HI, Gustafson T, Laffin B, Porter WW. (2006). Differential transcriptional regulation by mouse single-minded 2S. J Biol Chem 281: 1083910848.
22. Milde-Langosch K, Loning T, Bamberger AM. (2003). Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins. Breast Cancer Res Treat 79: 175-185.
23. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T et al. (1993). Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 90: 2207-2211.
24. Nielsen LL, Discafani CM, Gurnani M, Tyler RD. (1991). Histopathology of salivary and mammary gland tumors in transgenic mice expressing a human Ha-ras oncogene. Cancer Res 51: 37623767.
25. Sansone P, Storci G, Giovannini C, Pandolfi S, Pianetti S, Taffurelli M et al. (2007). p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres. Stem Cells 25: 807-815.
26. Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ et al. (1998). C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev 12: 1917-1928.
27. Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC. (2005). Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Cancer Res 65: 861-867.
28. Shuman JD, Sebastian T, Kaldis P, Copeland TD, Zhu S, Smart RC et al. (2004). Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12. Mol Cell Biol 24: 7380-7391.
29. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P. (1987). Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49: 465-475.
30. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712.
31. Stylianou S, Clarke RB, Brennan K. (2006). Aberrant activation of Notch signaling in human breast cancer. Cancer Res 66: 1517-1525.
32. Sundaram MV. (2005). The love-hate relationship between Ras and Notch. Genes Dev 19: 1825-1839.
33. von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE, Boss GR. (2000). Ras activation in human breast cancer. Breast Cancer Res Treat 62: 51-62.
34. Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A et al. (2002). Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 8: 979-986.
35. Yu Q, Geng Y, Sicinski P. (2001). Specific protection against breast cancers by cyclin D1 ablation. Nature 411: 1017-1021.
36. Zahnow CA. (2002). CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res 4: 113-121.
37. Zahnow CA, Cardiff RD, Laucirica R, Medina D, Rosen JM. (2001). A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Res 61: 261-269.
38. Zahnow CA, Younes P, Laucirica R, Rosen JM. (1997). Overexpression of C/EBPbeta-LIP, a naturally occurring, dominantnegative transcription factor, in human breast cancer. J Natl Cancer Inst 89: 1887-1891.